Axsome Therapeutics Inc logo

Axsome Therapeutics Inc

1
NAS:AXSM (USA)  
$ 63.76 -3.02 (-4.52%) 08:08 PM EST
P/E:
At Loss
P/B:
10.69
Market Cap:
$ 3.01B
Enterprise V:
$ 2.90B
Volume:
750.29K
Avg Vol (2M):
699.83K
Also Trade In:
Volume:
750.29K
Market Cap $:
3.01B
PE Ratio:
At Loss
Avg Vol (2M):
699.83K
Enterprise Value $:
2.90B
PB Ratio:
10.69

Business Description

Description
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.
Name Current Vs Industry Vs History
Cash-To-Debt 2.37
Equity-to-Asset 0.46
Debt-to-Equity 0.66
Debt-to-EBITDA -1.12
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.55
Distress
Grey
Safe
Beneish M-Score 13.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 13.01
9-Day RSI 21.03
14-Day RSI 27.99
6-1 Month Momentum % 29.71
12-1 Month Momentum % 80.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.52
Quick Ratio 4.44
Cash Ratio 3.8
Days Inventory 151.35
Days Sales Outstanding 74.55
Days Payable 667.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6
Shareholder Yield % -28.86

Financials (Next Earnings Date:2023-11-07 Est.)

AXSM's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AXSM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Axsome Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 182.494
EPS (TTM) ($) -4.28
Beta 0.32
Volatility % 66.63
14-Day RSI 27.99
14-Day ATR ($) 2.944337
20-Day SMA ($) 74.6685
12-1 Month Momentum % 80.21
52-Week Range ($) 38.87 - 91.29
Shares Outstanding (Mil) 47.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Axsome Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Axsome Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

Axsome Therapeutics Inc Frequently Asked Questions

What is Axsome Therapeutics Inc(AXSM)'s stock price today?
The current price of AXSM is $63.76. The 52 week high of AXSM is $91.29 and 52 week low is $38.87.
When is next earnings date of Axsome Therapeutics Inc(AXSM)?
The next earnings date of Axsome Therapeutics Inc(AXSM) is 2023-11-07 Est..
Does Axsome Therapeutics Inc(AXSM) pay dividends? If so, how much?
Axsome Therapeutics Inc(AXSM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1